Synata Bio
PrivateLast Round
Grant
Nov 19, 2024
Total Funding Raised
$324M
Company Overview
Synata Bio is an industrial chemicals company that develops fermentation technology to convert waste gases and synthesis gas into ethanol and other chemical products.
Sector
Energy & Sustainability
Verticals
Carbon Capture, Circular Economy, Alternative Fuels, Clean Manufacturing, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synata Bio Comparables
Compare Synata Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jupeng Bio | 84% | |
| Phase Biolabs | 81% | |
| LanzaTech | 80% | |
Synata Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 19, 2024 | ||||
| Series D | Aug 22, 2011 | ||||
| Debt | Jan 20, 2011 | ||||
| Series C Extension | Apr 29, 2010 | ||||
| Series C | Dec 8, 2008 | ||||
Series B | Mar 21, 2008 |
Synata Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series B, Series A, Series C |
| Blackstone | Series D, Series C |
| Khosla Ventures | Series B, Series C Extension, Series A, Series D, Series C |
| TotalEnergies Carbon Neutrality Ventures | Series D |
| National Development and Reform Commission | Grant |
| Advanced Technology Ventures | Series B, Series C Extension, Series A, Series C |
| Sumitomo Corporation | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2024
Grew 17% QoQ, from 30 to 35 employees.
- Mar 21, 2008
$20M round with participation from Khosla Ventures and General Motors.
Synata Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synata Bio's valuation, stock price, and market status.